Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Active Biotech on directed new share issue
Mandate

Vinge advises Active Biotech on directed new share issue

April 06, 2010

The biotechnology company, Active Biotech (NASDAQ OMX Stockholm) is carrying out a directed new issue of shares for approximately SEK 149 million to funds managed by Sectoral Asset Management Inc. Vinge is acting for Active Biotech.

Vinge’s team consists of Erik Sjöman and Christian Lindhé.

Related

Vinge has advised Investor in connection with acquisition of shares in EQT

 Vinge has advised Investor in connection with an acquisition of 12,500,000 shares in EQT AB from Wallenberg Investments for a total consideration of approximately SEK 3.5 billion.
October 19, 2026

Vinge has advised Oncopeptides in connection with a directed share issue

 Vinge has advised Oncopeptides in connection with a directed share issue, whereby Oncopeptides raises proceeds of SEK 100 million.
October 16, 2026

Vinge advises KGAL on its divestment of a Nordic wind portfolio to Enordic Evergreen

 Vinge has advised KGAL on the divestment of a Nordic onshore wind portfolio to Enordic Evergreen.
October 14, 2026